College of Pharmacy
View Related Pages
HelixTalk
View Related Pages
This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.
How Do I Listen?
HelixTalk is available via Apple Podcasts (or by searching for HelixTalk), by subscribing to our RSS feed, subscribing to our mailing list, or by listening to any episode in your browser (below).
HelixTalk Episodes
HelixTalk #200 - 200 Episodes, One Big Conversation: Dr. Aron Sousa on RFU and Community Impact
Date posted: October 9, 2026, 3:55 pm
In this milestone 200th episode of HelixTalk, we interview Dr. Aron Sousa, President and CEO of Rosalind Franklin University, about his career at Michigan State University, the importance of community engagement in higher education, and his vision for RFUMS. We explore Rx Kids, an innovative program providing financial support to families during pregnancy and infancy, as well as RFUMS initiatives aimed at improving the health and well-being of surrounding communities.
HelixTalk #199 - Axe the Anaerobes, Drop the Docuste, Free the Fluids
Date posted: September 18, 2026, 1:18 pm
In this episode, we review three medical myths, highlighted in the “Things We Do For No Reason” series of the Journal of Hospital Medicine, including anaerobic coverage for aspiration pneumonia, fluid restriction in heart failure, and docusate for constipation.
HelixTalk #198 - Lp(a), ApoB, and CAC: Navigating the 2026 Dyslipidemia Guideline Alphabet Soup
Date posted: June 4, 2026, 9:19 am
In this episode, we review key updates from the 2026 ACC-AHA Guidelines on the Management of Dyslipidemia.
HelixTalk #197 - Sweet Deal of Updates in Diabetes Pharmacotherapy from the ADA 2026 Standards of Care
Date posted: April 3, 2026, 3:05 pm
In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, particularly focusing on changes in pharmacotherapy recommendations and the supporting evidence.